802 Dalton impurity; European Pharmacopoeia; HPLC MS MS; Rifaximin; Spectroscopic techniques; Structural elucidation
Indexed keywords
RIFAXIMIN;
ARTICLE;
BATCH PROCESS;
CARBON NUCLEAR MAGNETIC RESONANCE;
COLUMN CHROMATOGRAPHY;
CONTROLLED STUDY;
DRUG IMPURITY;
DRUG ISOLATION;
DRUG PURIFICATION;
DRUG QUALITY;
DRUG STRUCTURE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ANALYSIS;
ANTI-BACTERIAL AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG CONTAMINATION;
MAGNETIC RESONANCE SPECTROSCOPY;
MOLECULAR STRUCTURE;
PHARMACOPOEIAS AS TOPIC;
RIFAMYCINS;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
SPECTROPHOTOMETRY, ULTRAVIOLET;
SPECTROSCOPY, FOURIER TRANSFORM INFRARED;
TECHNOLOGY, PHARMACEUTICAL;
Rifaximin (L/105), a new intestinal antibiotic: pharmacokinetic study after single oral administration of 3H-Rifaximin to rats
Cellai L., Colosimo M., Marchi E., Venturini A.P., and Zanolo G. Rifaximin (L/105), a new intestinal antibiotic: pharmacokinetic study after single oral administration of 3H-Rifaximin to rats. Chemioterapia 3 (1984) 373-377
In vitro activity of Rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic bacteria, including ammonia-producing species
Marchese A., Salerno A., Pesce A., Debbia E.A., and Schito G.C. In vitro activity of Rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic bacteria, including ammonia-producing species. Chemotherapy 46 (2000) 253-266
A randomized, double-blind, placebo-controlled trial of Rifaximin to prevent travelers' diarrhea
DuPont H.L., Jiang Z.D., Okhuysen P.C., Ericsson C.D., de la Cabada F.J., Ke S., DuPont M.W., and Martinez-Sandoval F. A randomized, double-blind, placebo-controlled trial of Rifaximin to prevent travelers' diarrhea. Ann. Intern. Med. 142 (2005) 805-812
Rifaximin, a nonabsorbed oral antibiotic prevents shigellosis after experimental challenge
Taylor D.N., McKenzie R., Durbin A., Carpenter C., Atzinger C.B., Haake R., and Bourgeois A.L. Rifaximin, a nonabsorbed oral antibiotic prevents shigellosis after experimental challenge. Clin. Infect. Dis. 42 (2006) 1283-1288
V. Cannata, G.F. Tamagnone, Process for the synthesis of pyrido-imidazo rifamycins, PCT 4,557,866 Pubbl. (1985).
V. Cannata, G.F. Tamagnone, Process for the synthesis of pyrido-imidazo rifamycins, PCT 4,557,866 Pubbl. (1985).
6
0034985479
Amycolatopsis rubida sp. Nov., a new Amycolatopsis species from soil
Huang Y., Qi W., Lu Z., Liu Z., and Goodfellow M. Amycolatopsis rubida sp. Nov., a new Amycolatopsis species from soil. Int. J. Syst. Evol. Microbiol. 51 (2001) 1093-1097
NMR studies of a new class of Rifaximin-derived molecules: Rifaximin OR (Open Ring)
Rossi C., Marchettini N., Bonechi C., Donati A., Corbini G., and Corti P. NMR studies of a new class of Rifaximin-derived molecules: Rifaximin OR (Open Ring). J. Chem. Res. (S) (1996) 268-269
